Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not?
Background: The new coronavirus outbreak quickly filled hospital beds and stunned the world. Intensive care is required for 5% of patients, and the mortality rate for critically ill patients is 49%. The “cytokine storm” is considered as the main cause of pathogenesis for coronavirus disease-19 (COVI...
Main Authors: | Saeed Abbasi, Zohre Naderi, Babak Amra, Abdolamir Atapour, Seyed Amir Dadkhahi, Mohammad Javad Eslami, Mohammad Reza Hajian, Marzieh Hashemi, Seyed Taghi Hashemi, Bijan Iraj, Farzin Khorvash, Samane Madadi, Hossein Mahjoubi Pour, Marjan Mansourian, Majid Rezvani, Ramin Sami, Forough Soltaninejad, Shahrzad Shahidi, Sahar Vahdat, Zahra Zamani, Firouzeh Moeinzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=34;epage=34;aulast=Abbasi |
Similar Items
-
Amitriptyline Cardiac Toxicity Treated with Hemoperfusion
by: Nurdan Ünlü, et al.
Published: (2017-04-01) -
Charcoal hemoperfusion in bupropion overdose
by: Hızır Ufuk Akdemir, et al.
Published: (2014-10-01) -
Hemoperfusion Can Control Inflammatory Factors in Patients with COVID-19
by: Mohammad Hassani, et al.
Published: (2022-03-01) -
Fabrication of nanodiamonds/polyaniline nanocomposite for bilirubin adsorption in hemoperfusion
by: Futao Wang, et al.
Published: (2024-12-01) -
Does Hemoperfusion Increase Survival in Acute Paraquat Poisoning? A Retrospective Multicenter Study
by: Ying-Tse Yeh, et al.
Published: (2020-10-01)